Cloud computing approaches for prediction of ligand binding poses and pathways

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Lawrenz, Morgan ^a   Shukla, Diwakar ^a,b   Pande, Vijay S ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FK 506 BINDING PROTEIN; LIGAND; PROTEIN BINDING;

BINDING SITE; CHEMISTRY; CLOUD COMPUTING; MOLECULAR DYNAMICS; PROTEIN ENGINEERING; THERMODYNAMICS; X RAY CRYSTALLOGRAPHY;

BINDING SITES; CLOUD COMPUTING; CRYSTALLOGRAPHY, X-RAY; LIGANDS; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; PROTEIN ENGINEERING; TACROLIMUS BINDING PROTEIN 1A; THERMODYNAMICS;

EID: 84928383101     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07918     Document Type: Article

References (44)

1. Chae, P. S. et al.Maltose-neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins. Nat. Methods 7, 1003-1008 (2010).
2. Hoeppner, A., Schmitt, L., Smits, S. Proteins and their ligands: Their importance and how to crystallize them. Advanced Topics on Crystal Growth Ferreira, S. O. (ed.) (InTech, 2013).
3. Feixas, F., Lindert, S., Sinko, W.& McCammon, J. A. Exploring the role of receptor flexibility in structure-based drug discovery. Biophys. Chem. 186, 31-45 (2014).
4. Schneider, G. Virtual screening: an endless staircase Nat. Rev. Drug Discovery 9, 273-276 (2010).
5. Dror, R. O. et al. Activation mechanism of the 2-adrenergic receptor. Proc. Natl. Acad. Sci. U. S. A. 108, 18684-18689 (2011).
6. Shan, Y. et al. How does a drug molecule find its target binding site J. Am. Chem. Soc. 133, 9181-9183 (2011).
7. Buch, I., Giorgino, T. Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations. Proc. Natl. Acad. Sci. U. S. A 108, 10184-10189 (2011).
8. Silva, D.-A., Bowman, G. R., Sosa-Peinado, A., Huang, X. A Role for Both Conformational Selection and Induced Fit in Ligand Binding by the LAO Protein. PLoS Comput. Biol. 7, e1002054 (2011).
9. Voelz, V. A., Bowman, G. R., Beauchamp, K., Pande, V. S. Molecular simulation of ab initio protein folding for amillisecond folder NTL9(1-39). J. Am. Chem. Soc. 132, 1526-1528 (2010).
10. Kohlhoff, K. J. et al. Cloud-based simulations on Google Exacycle reveal ligand modulation of GPCR activation pathways. Nature Chem. 6, 15-21 (2013).
11. Shukla, D., Meng, Y., Roux, B., Pande, V. S. Activation pathway of Src kinase reveals intermediate states as targets for drug design. Nature Comm. 5, 3397 (2014).
12. Chen, Y. G., Liu, F., Massague, J. Mechanism of TGF receptor inhibition by FKBP12. EMBO J. 16, 3866-387 (1997).
13. Griffith, J. P. et al. X-ray structure of calcineurin inhibited by the immunophilinimmunosuppressant FKBP12-FK506 complex. Cell 82, 507-522 (1995).
14. Chong, Z. Z., Shang, Y. C., Zhang, L., Wang, S.Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders. Oxid. Med. Cell Longev. 3, 374-391 (2010).
15. Sugata, H., Matsuo, K., Nakagawa, T., Takahashi, M. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles. Neurosci. Lett. 459 96-99 (2009).
16. Bowman, G. R., Geissler, P. L. Equilibrium fluctuations of a single folded protein reveal amultitude of potential cryptic allosteric sites. Proc. Natl. Acad. Sci. U. S. A. 109, 11681-11686 (2012).
17. Weber, J., Pande, V. Characterization and rapid sampling of protein folding markov state model topologies. J. Chem. Theo. Comput. 7, 3405-3411 (2011).
18. Shirts, M., Pande, V. S. Screen savers of the world unite. Science 290, 1903-1904 (2006).
19. Burkhard, P., Hommel, U., Sanner, M., Walkinshaw, M. D. The discovery of steroids and other novel FKBP inhibitors using a molecular docking program. J. Mol. Biol. 287, 853-858 (1999).
20. Weinan, E., Vanden-Eijnden, E. Transition-path theory and path-finding algorithms for the study of rare events. Annu. Rev. Phys. Chem. 61, 391-420 (2010).
21. Metzner, P., Schute, C., Vanden-Eijnden, E. Transition path theory for markov jump processes. Multiscale Model Sim. 7, 1192-1219 (2009).
22. Mustafi, S. M. et al. Structural basis of conformational transitions in the active site and 80's loop in the FK506-binding protein FKBP12. Biochem. J. 458, 525-536 (2014).
23. Fischer, S., Michnick, S., Karplus, M. Amechanism for rotamase catalysis by the FK506 binding protein (FKBP). Biochemistry 32, 13830-13837 (1993).
24. Jain, A. N. Surflex-Dock 2.1: robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search. J. Comput.-Aided Mol. Des. 21, 281-306 (2007).
25. Rotonda, J., Burbaum, J. J., Chan, H. K., Marcy, A. I., Becker, J. W. Improved calcineurin inhibition by yeast FKBP12-drug complexes. Crystallographic and functional analysis. J. Biol. Chem. 268, 7607-7609 (1993).
26. Hess, B., Kutzner, C., van der Spoel, D., Lindahl, E. Gromacs 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theo. Comput. 4, 435-447 (2008).
27. Lindorff-Larsen, K. et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins: Struct., Funct., Bioinf. 78, 1950-1958 (2010).
28. Fujitani, H. et al. Direct calculation of the binding free energies of FKBP ligands. J. Chem. Phys. 123, 084108 (2005).
29. Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., Case, D. A. Development and testing of a general amber force field. J. Comput. Chem. 25, 1157-1174 (2004).
30. Sousa da Silva, A., Vranken, W. Acpype-antechamber python parser interface. BMC Research Notes 5, 367 (2012).
31. Jorgensen, W., Chandrasekhar, J., Madura, J., Impey, R., Klein, M. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926 (1983).
32. Hess, B., Bekker, H., Berendsen,H., Fraaije, J. et al. Lincs: a linear constraint solver for molecular simulations. J. Comp. Chem. 18, 1463-1472 (1997).
33. Darden, T., York, D., Pedersen, L. Particle mesh ewald: An nlog (n) method for ewald sums in large systems. J. Chem. Phys. 98, 10089 (1993).
34. Hoover, W. Canonical dynamics: Equilibrium phase-space distributions. Phys. Rev. A 31, 1695-1697 (1985).
35. Parrinello, M. Polymorphic transitions in single crystals: A new molecular dynamics method. J. Appl. Phys. 52, 7182 (1981).
36. Beauchamp, K. A. et al. MSMBuilder2: Modeling Conformational Dynamics at the Picosecond to Millisecond Scale. J. Chem. Theory Comput. 7, 3412-3419 (2011).
37. Bowman, G. R., Beauchamp, K. A., Boxer, G., Pande, V. S. Progress and challenges in the automated construction of markov state models for full protein systems. J. Chem. Phys. 131, 124101 (2009).
38. Chodera, J. D., Singhal, N., Pande, V. S., Dill, K. A., Swope, W. C. Automatic discovery of metastable states for the construction of Markov models of macromolecular conformational dynamics. J. Chem. Phys. 126, 155101 (2007).
39. Prinz, J.-H. et al.Markov models of molecular kinetics: Generation and validation. J. Chem. Phys. 134, 174105 (2011).
40. Swope, W. C., Pitera, J. W., Suits, F. Describing protein folding kinetics by molecular dynamics simulations. 1. Theory. J. Phys. Chem. 108, 65716581 (2004).
41. Lapelosa, M., Gallicchio, E., Levy, R. M. Conformational Transitions and Convergence of Absolute Binding Free Energy Calculations. J. Chem. Theory Comput. 111215080904009 (2011).
42. Humphrey, W., Dalke, A., Schulten, K. Vmd: visual molecular dynamics. J. Mol. Graph. 14, 33-38 (1996).
43. Holt, D. A. et al. Design, synthesis, and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structures of their complexes with FKBP12. J. Am. Chem. Soc. 115, 9925-9938 (1993).
44. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213-221 (2010).